Lexeo Therapeutics (LXEO) Revenue: 2022-2023
Historic Revenue for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$50,000.
- Lexeo Therapeutics' Revenue rose 7.41% to -$50,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$205,000, marking a year-over-year change of. This contributed to the annual value of -$137,000 for FY2024, which is 33.17% up from last year.
- Per Lexeo Therapeutics' latest filing, its Revenue stood at -$50,000 for Q4 2023, which was up 3.85% from -$52,000 recorded in Q3 2023.
- In the past 5 years, Lexeo Therapeutics' Revenue ranged from a high of $531,000 in Q3 2022 and a low of -$54,000 during Q4 2022.
- In the last 2 years, Lexeo Therapeutics' Revenue had a median value of -$51,000 in 2023 and averaged $45,333.
- Examining YoY changes over the last 5 years, Lexeo Therapeutics' Revenue showed a top increase of 7.41% in 2023 and a maximum decrease of 109.79% in 2023.
- Over the past 2 years, Lexeo Therapeutics' Revenue (Quarterly) stood at -$54,000 in 2022, then grew by 7.41% to -$50,000 in 2023.
- Its last three reported values are -$50,000 in Q4 2023, -$52,000 for Q3 2023, and -$53,000 during Q2 2023.